pirfenidone has been researched along with Alveolar Echinococcosis, Hepatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hou, J; Jiang, H; Liao, Y; Liao, Z; Liu, P; Wang, E; Wang, L; Wang, X; Wu, X; Xu, X | 1 |
1 other study(ies) available for pirfenidone and Alveolar Echinococcosis, Hepatic
| Article | Year |
|---|---|
A combination of pirfenidone and TGF-β inhibition mitigates cystic echinococcosis-associated hepatic injury.
Topics: Animals; Echinococcosis, Hepatic; Imidazoles; Liver; Mice; Pyridones; Quinoxalines; Transforming Growth Factor beta1 | 2021 |